Johnson & Johnson stock: Healthcare group trades pre-market 0.31 percent above Xetra close

Published on 10/26/2026 at 08:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson develops treatments and solutions for patients and professionals. At Lang & Schwarz the stock trades pre-market at EUR 235.78 on October 26, 2026, 0.31 percent above the Xetra close of October 23, 2026.

Healthcare business and market context

Johnson & Johnson operates in healthcare innovation, developing treatments and solutions for patients and professionals.
The relevant home-market benchmark is the S&P 500 in the United States.
Johnson & Johnson stock trades pre-market at EUR 235.78 at 8:18 a.m. CET at Lang & Schwarz on October 26, 2026, 0.31 percent above the Xetra close of October 23, 2026.

Isometrische Darstellung von Labor, Fertigung, Verpackung und Logistik — Isometrische 3D-Illustration zeigt Wertschöpfungskette der Pharmaproduktion von Johnson & Johnson, ISIN US4781601046, Schritt für Schritt, Illustration mit AI erstellt.

Johnson & Johnson operates in healthcare innovation, developing treatments and solutions for patients and professionals, according to its investor-relations website. Johnson & Johnson stock trades pre-market at EUR 235.78 at 8:18 a.m. CET at Lang & Schwarz on October 26, 2026, 0.31 percent above the Xetra close of October 23, 2026 (EUR 235.05).

Early indication before Xetra

The difference is plus EUR 0.73, placing the stock above the reference level. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Johnson & Johnson stock.